COMPANY PROFILE // THE 014 REPORT
biote Corp.
BTMD (Nasdaq) · Formerly: Haymaker Acquisition Corp. III
Assembled from 2 government sources in 0.2 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
No flag from the records checked. 26 of 26 lists and sources checked came back clear (panel below).
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
biote Corp. is an SEC-registered operating company in medicinal chemicals & botanical products, based in Irving, TX; listed as BTMD (Nasdaq).[source] It reported revenue of $192.2 million for the fiscal year ended 2025-12-31.[source] It has filed 37 documents with the SEC in the last 12 months; the latest is a SCHEDULE 13G/A, filed 2026-11-12.[source] Its largest institutional holders on 13F filings are 325 CAPITAL LLC, Bandera Partners LLC, VANGUARD CAPITAL MANAGEMENT LLC (as of 2026-06-30).[source] Every list and source checked for this page came back clear (26 of 26), dated in the checks panel.[source]
- red0
- amber0
- info0
- 325 CAPITAL LLC$8.6M
- Bandera Partners LLC$3.9M
- VANGUARD CAPITAL MANAGEMENT LLC$2.1M
- MILLENNIUM MANAGEMENT LLC$824K
- DIMENSIONAL FUND ADVISORS LP$816K
- BlackRock, Inc.$692K
- CITADEL ADVISORS LLC$569K
- RICE HALL JAMES & ASSOCIATES, LLC$497K
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Beer Marc D · Executive Chairman (Director,Officer) · latest Form 4 2025-04-02 · filing · LinkedIn search
- Conlon Mary Elizabeth · General Counsel (Officer) · latest Form 4 2025-04-02 · filing · LinkedIn search
- Peterson Robert Charles · Chief Financial Officer (Officer) · latest Form 4 2025-04-02 · filing · LinkedIn search
- Barrera Richard R · Director,10% owner · latest Form 4 2025-06-11 · filing · LinkedIn search
- Cone Stephen Mark · Director · latest Form 4 2025-05-14 · filing · LinkedIn search
- HEYER ANDREW R · Director · latest Form 4 2025-05-14 · filing · LinkedIn search
- HEYER STEVEN J · Director · latest Form 4 2025-05-14 · filing · LinkedIn search
- Jacoby Dana Lynn · Director · latest Form 4 2025-05-14 · filing · LinkedIn search
- MORRIS DEBRA L · Director · latest Form 4 2025-05-15 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
Legal counsel, as publicly named
- Peter Byrne Peter Byrne Cooley LLP · Exhibit 5.1 legal opinion, S-8 filed 2026-04-14
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001819253 | source |
| EIN | 85-1791125 | source |
| Business address (SEC) | 1875 W. WALNUT HILL LN #100, IRVING, TX, 75038 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-16 · in 116 days · Next 10-K due (period ended 2026-12-31; Accelerated filer<br>Smaller reporting company<br>Emerging growth company) (computed from the fiscal year end and filer status)
- 2027-05-10 · in 171 days · Next 10-Q due (period ended 2027-03-31; Accelerated filer<br>Smaller reporting company<br>Emerging growth company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2833 (medicinal chemicals & botanical products): 43 companies in our records share this code.
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- USANA HEALTH SCIENCES INC · 103 SEC filings in 12 months
- Definium Therapeutics, Inc. · 98 SEC filings in 12 months
- Curaleaf Holdings, Inc. · 75 SEC filings in 12 months
- MARIMED INC. · 73 SEC filings in 12 months
- AURORA CANNABIS INC · 63 SEC filings in 12 months
- Canopy Growth Corp · 63 SEC filings in 12 months · 3 flags
- Trulieve Cannabis Corp. · 63 SEC filings in 12 months · 1 flag
- Cronos Group Inc. · 54 SEC filings in 12 months
- Tilray Brands, Inc. · 51 SEC filings in 12 months · 1 flag
- IM Cannabis Corp. · 51 SEC filings in 12 months
- Jushi Holdings Inc. · 47 SEC filings in 12 months
- MediWound Ltd. · 46 SEC filings in 12 months
SHARED PEOPLE · SHARED ADDRESS
Network neighbours
Shared directors and officers
- Lovesac Co · HEYER ANDREW R
- ONESPAWORLD HOLDINGS Ltd · HEYER ANDREW R
- ARKO Corp. · HEYER ANDREW R
- ARKO Petroleum Corp. · HEYER ANDREW R
- ARKO Corp. · HEYER STEVEN J
- Progyny, Inc. · MORRIS DEBRA L
- Rexford Industrial Realty, Inc. · MORRIS DEBRA L
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-09 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-11-04 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-08-07 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-05 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-06-17 officer change 8-K/A items 5.02 · SEC EDGAR
- 2026-06-02 officer change 8-K items 5.02,7.01,9.01 · SEC EDGAR
- 2026-05-18 filing 8-K items 5.07 · SEC EDGAR
- 2026-05-11 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-05-06 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-04-14 filing S-8 · SEC EDGAR
- 2026-04-03 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-04-02 filing ARS · SEC EDGAR
- 2026-04-02 filing DEFA14A · SEC EDGAR
- 2026-04-02 filing Proxy statement · SEC EDGAR
- 2026-03-13 filing Annual report (10-K) · SEC EDGAR
- 2026-03-11 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-01-26 filing 8-K items 8.01 · SEC EDGAR
- 2025-11-07 filing Quarterly report (10-Q) · SEC EDGAR
- 2025-11-05 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2025-08-08 filing Quarterly report (10-Q) · SEC EDGAR
- 2025-08-06 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2025-06-12 filing SCHEDULE 13D · SEC EDGAR
- 2025-06-09 officer change 8-K items 5.02,7.01,9.01 · SEC EDGAR
- 2025-06-05 officer change 8-K items 5.02 · SEC EDGAR
- 2025-05-15 insider First Form 3/4/5 on record for MORRIS DEBRA L (Director) · SEC Forms 3/4/5
- 2025-05-14 filing 8-K items 5.07 · SEC EDGAR
- 2025-05-14 insider First Form 3/4/5 on record for Cone Stephen Mark (Director) · SEC Forms 3/4/5
- 2025-05-14 insider First Form 3/4/5 on record for HEYER ANDREW R (Director) · SEC Forms 3/4/5
- 2025-05-14 insider First Form 3/4/5 on record for HEYER STEVEN J (Director) · SEC Forms 3/4/5
- 2025-05-14 insider First Form 3/4/5 on record for Jacoby Dana Lynn (Director) · SEC Forms 3/4/5
170 earlier entries
- 2025-05-09 filing Quarterly report (10-Q)
- 2025-05-07 filing 8-K items 2.02,2.05,9.01
- 2025-05-05 filing DEFR14A
- 2025-04-24 officer change 8-K items 5.02
- 2025-04-11 filing EFFECT
- 2025-04-09 filing POS AM
- 2025-04-09 filing S-8
- 2025-04-03 filing ARS
- 2025-04-03 filing DEFA14A
- 2025-04-03 filing Proxy statement
- 2025-04-02 insider First Form 3/4/5 on record for Beer Marc D (Executive Chairman)
- 2025-04-02 insider First Form 3/4/5 on record for Conlon Mary Elizabeth (General Counsel)
- 2025-04-02 insider First Form 3/4/5 on record for Peterson Robert Charles (Chief Financial Officer)
- 2025-04-02 insider First Form 3/4/5 on record for Barrera Richard R (Director,10% owner)
- 2025-03-17 filing 8-K items 7.01,9.01
- 2025-03-14 filing Annual report (10-K)
- 2025-03-12 filing 8-K items 2.02,9.01
- 2025-01-30 officer change 8-K items 5.02,7.01,9.01
- 2024-11-13 filing 424B3
- 2024-11-13 filing 424B3
- 2024-11-12 filing Quarterly report (10-Q)
- 2024-11-12 filing 8-K items 2.02,9.01
- 2024-08-09 filing 424B3
- 2024-08-09 filing 424B3
- 2024-08-09 filing Quarterly report (10-Q)
- 2024-08-08 filing 8-K items 2.02,9.01
- 2024-07-05 filing 8-K items 1.01
- 2024-07-03 officer change 8-K items 5.02
- 2024-06-21 filing 8-K items 1.01,7.01,9.01
- 2024-05-24 filing 8-K items 5.07
- 2024-05-10 filing 424B3
- 2024-05-10 filing 424B3
- 2024-05-10 filing Quarterly report (10-Q)
- 2024-05-07 filing 8-K items 2.02,9.01
- 2024-04-29 filing 8-K items 1.01,7.01,9.01
- 2024-04-11 filing ARS
- 2024-04-11 filing DEFA14A
- 2024-04-11 filing Proxy statement
- 2024-04-09 filing 424B3
- 2024-04-09 filing 424B3
- 2024-04-03 filing S-8
- 2024-04-02 filing EFFECT
- 2024-04-02 filing EFFECT
- 2024-04-01 filing POS AM
- 2024-04-01 filing POS AM
- 2024-03-15 filing Annual report (10-K)
- 2024-03-14 filing 8-K items 7.01,9.01
- 2024-03-12 filing 8-K items 2.02,9.01
- 2024-02-21 filing 424B3
- 2024-02-21 filing 424B3
- 2024-02-20 filing 8-K items 1.01,7.01,9.01
- 2024-01-25 filing 8-K items 8.01,9.01
- 2024-01-17 filing 8-K items 2.02,7.01,9.01
- 2024-01-17 filing 424B3
- 2024-01-17 filing 424B3
- 2024-01-11 officer change 8-K items 5.02,7.01,9.01
- 2023-11-14 filing 424B3
- 2023-11-14 filing 424B3
- 2023-11-13 filing Quarterly report (10-Q)
- 2023-11-07 filing 8-K items 2.02,9.01
- 2023-10-24 filing UPLOAD
- 2023-10-05 filing CORRESP
- 2023-09-21 filing UPLOAD
- 2023-08-17 filing 144
- 2023-08-11 filing 424B3
- 2023-08-11 filing 424B3
- 2023-08-11 filing Quarterly report (10-Q)
- 2023-08-10 filing 8-K items 2.02,9.01
- 2023-07-07 filing 25-NSE
- 2023-06-15 filing SC 13D
- 2023-06-09 filing 424B3
- 2023-06-09 filing 424B3
- 2023-06-09 filing SC TO-I/A
- 2023-06-09 filing 425
- 2023-06-09 filing 8-K items 1.01,3.03,5.07,8.01,9.01
- 2023-06-07 filing EFFECT
- 2023-06-07 filing 424B3
- 2023-06-07 filing 424B3
- 2023-06-07 filing 8-K items 8.01,9.01
- 2023-06-07 filing 424B3
- 2023-06-06 filing CORRESP
- 2023-05-23 filing CORRESP
- 2023-05-23 filing S-4/A
- 2023-05-19 filing 8-K items 5.07
- 2023-05-17 filing UPLOAD
- 2023-05-16 filing S-4/A
- 2023-05-16 filing 424B3
- 2023-05-16 filing 424B3
- 2023-05-15 filing DEL AM
- 2023-05-12 filing Quarterly report (10-Q)
- 2023-05-10 filing 424B3
- 2023-05-10 filing 424B3
- 2023-05-10 filing 425
- 2023-05-09 filing SC TO-I
- 2023-05-09 filing 8-K items 2.02,8.01,9.01
- 2023-05-09 filing S-4
- 2023-04-24 filing S-8
- 2023-04-14 filing ARS
- 2023-04-14 filing Proxy statement
- 2023-04-13 filing 424B3
- 2023-04-13 filing 424B3
- 2023-04-11 filing EFFECT
- 2023-04-11 filing EFFECT
- 2023-04-06 filing POS AM
- 2023-04-06 filing POS AM
- 2023-03-30 filing 424B3
- 2023-03-30 filing 424B3
- 2023-03-30 filing 424B3
- 2023-03-30 filing 424B3
- 2023-03-29 filing Annual report (10-K)
- 2023-03-29 filing 10-Q/A
- 2023-03-29 filing 10-Q/A
- 2023-03-28 filing 8-K items 2.02,9.01
- 2023-03-24 filing 424B3
- 2023-03-24 filing 424B3
- 2023-03-24 filing 8-K items 4.02
- 2023-02-22 officer change 8-K items 5.02,5.03,9.01
- 2023-01-06 filing 424B4
- 2023-01-04 filing EFFECT
- 2023-01-03 filing CORRESP
- 2023-01-03 filing CORRESP
- 2023-01-03 filing S-1/A
- 2022-12-15 filing UPLOAD
- 2022-12-12 filing Registration (S-1)
- 2022-11-14 filing 424B3
- 2022-11-14 filing 424B3
- 2022-11-14 filing 424B3
- 2022-11-14 filing Quarterly report (10-Q)
- 2022-11-08 filing 8-K items 2.02,9.01
- 2022-11-07 filing 424B3
- 2022-11-07 filing 424B3
- 2022-11-07 officer change 8-K items 5.02,7.01,9.01
- 2022-10-11 filing 8-K items 7.01,9.01
- 2022-08-26 filing CERT
- 2022-08-25 filing 424B3
- 2022-08-25 filing 424B3
- 2022-08-25 filing 8-A12B
- 2022-08-25 filing 8-K items 7.01,9.01
- 2022-08-24 filing 424B3
- 2022-08-24 filing 424B3
- 2022-08-24 officer change 8-K items 5.02,7.01,9.01
- 2022-08-16 filing 424B3
- 2022-08-16 filing 424B3
- 2022-08-15 filing Quarterly report (10-Q)
- 2022-08-15 filing 8-K/A items 2.02,9.01
- 2022-08-10 filing 8-K items 2.02,9.01
- 2022-08-09 filing 424B3
- 2022-08-05 filing EFFECT
- 2022-08-03 filing CORRESP
- 2022-08-03 filing S-8
- 2022-08-03 filing UPLOAD
- 2022-08-01 filing Registration (S-1)
- 2022-07-28 filing 424B3
- 2022-07-28 filing 8-K items 1.01,3.02,9.01
- 2022-07-19 filing EFFECT
- 2022-07-19 filing 424B3
- 2022-07-19 filing 424B3
- 2022-07-19 filing 8-K items 1.01,9.01
- 2022-07-19 filing 424B3
- 2022-07-19 filing 8-K items 3.01
- 2022-07-15 filing CORRESP
- 2022-07-11 filing CORRESP
- 2022-07-11 filing S-1/A
- 2022-07-08 filing UPLOAD
- 2022-06-28 filing CORRESP
- 2022-06-28 filing S-1/A
- 2022-06-24 filing UPLOAD
- 2022-06-22 filing S-1/A
- 2022-06-17 filing Registration (S-1)
- 2022-06-09 filing 8-K items 2.02,7.01,9.01
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-09 (within 30 days) 10-Q filed
- 2026-11-04 (within 30 days) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-07 (older) 10-Q filed
- 2026-08-05 (older) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-06-17 (older) 8-K/A filed: Item 5.02 officer or director change
- 2026-06-02 (older) 8-K filed: Item 5.02 officer or director change; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-05-18 (older) 8-K filed: Item 5.07 shareholder vote
- 2026-05-11 (older) 10-Q filed
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:BTMD The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
0 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1819253 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | BTMD / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| EIN | 851791125 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001819253 | SEC EDGAR / IRS |
| CUSIP | 090683103 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0001819253 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $192,219,000 | 2025-12-31 | 10-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax | as filed | 2026-11-20 11:17 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | $27,045,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-20 11:17 UTC | Report an error |
| Total assets (at 2025-12-31) | $107,613,000 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-20 11:17 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | -$58,539,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-20 11:17 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $24,123,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-20 11:17 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-20 11:17 UTC | Report an error |
| SIC industry | 2833 Medicinal Chemicals & Botanical Products | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-20 11:17 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-20 11:17 UTC | Report an error |
| Business address | 1875 W. WALNUT HILL LN #100, IRVING, TX, 75038 | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-20 11:17 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-20 11:17 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | $35,194,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-20 11:17 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $5,015,000 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-20 11:17 UTC | Report an error |
| Long-term debt (at 2025-12-31) | $103,125,000 | 2025-12-31 | 10-K, XBRL LongTermDebt | as filed | 2026-11-20 11:17 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $2,890,000 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-20 11:17 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-09 · accession 0001193125-26-453823
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $43,334,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-09 | 0001193125-26-453823 | 2026-11-20 11:17 UTC | Report an error |
| Net income (loss) | $407,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-09 | 0001193125-26-453823 | 2026-11-20 11:17 UTC | Report an error |
| Cash and cash equivalents | $8,851,000 | at 2026-09-30 | 10-Q | 2026-11-09 | 0001193125-26-453823 | 2026-11-20 11:17 UTC | Report an error |
| Contract liabilities, current | $2,412,000 | at 2026-09-30 | 10-Q | 2026-11-09 | 0001193125-26-453823 | 2026-11-20 11:17 UTC | Report an error |
| Contract liabilities, noncurrent | $678,000 | at 2026-09-30 | 10-Q | 2026-11-09 | 0001193125-26-453823 | 2026-11-20 11:17 UTC | Report an error |
| Debt due in the next 12 months | $3,125,000 | at 2026-09-30 | 10-Q | 2026-11-09 | 0001193125-26-453823 | 2026-11-20 11:17 UTC | Report an error |
| Debt due in year 2 | $4,688,000 | at 2026-09-30 | 10-Q | 2026-11-09 | 0001193125-26-453823 | 2026-11-20 11:17 UTC | Report an error |
| Debt due in year 3 | $7,813,000 | at 2026-09-30 | 10-Q | 2026-11-09 | 0001193125-26-453823 | 2026-11-20 11:17 UTC | Report an error |
| Debt due in year 4 | $9,375,000 | at 2026-09-30 | 10-Q | 2026-11-09 | 0001193125-26-453823 | 2026-11-20 11:17 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-09 Filing 10-Q filed
- 2026-11-04 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-07 Filing 10-Q filed
- 2026-08-05 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-06-17 Filing 8-K/A filed: Item 5.02 officer or director change
- 2026-06-02 Filing 8-K filed: Item 5.02 officer or director change; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-05-18 Filing 8-K filed: Item 5.07 shareholder vote
- 2026-05-11 Filing 10-Q filed
- 2026-05-06 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-04-14 Filing S-8 filed
- 2026-04-03 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-04-02 Filing ARS filed
- 2026-04-02 Filing DEFA14A filed
- 2026-04-02 Filing DEF 14A filed
- 2026-03-13 Filing 10-K filed
- 2026-03-11 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-01-26 Filing 8-K filed: Item 8.01 other event
- 2025-11-07 Filing 10-Q filed
- 2025-11-05 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2025-08-08 Filing 10-Q filed
- 2025-08-06 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2025-06-09 Filing 8-K filed: Item 5.02 officer or director change; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2025-06-05 Filing 8-K filed: Item 5.02 officer or director change
- 2025-05-14 Filing 8-K filed: Item 5.07 shareholder vote
- 2025-05-09 Filing 10-Q filed
8-K item text, as filed (excerpts)
- 2026-11-04 8-K Item 2.02, Results of Operations and Financial Condition
On November 4, 2026, biote Corp., a Delaware corporation (the “Company”) issued a press release to report the Company’s financial results for the third quarter ended September 30, 2026. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K (the “Report”). The information in this Item 2.02 and the attached Exhibit 99.1 are being furnished and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall they be deemed to be incorporated by reference in any filing… the 8-K · retrieved 2026-11-20 11:17 UTC - 2026-08-05 8-K Item 2.02, Results of Operations and Financial Condition
On August 5, 2026, biote Corp., a Delaware corporation (the “Company”) issued a press release to report the Company’s financial results for the second quarter ended June 30, 2026. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K (the “Report”). The information in this Item 2.02 and the attached Exhibit 99.1 are being furnished and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall they be deemed to be incorporated by reference in any filing made by… the 8-K · retrieved 2026-11-20 11:17 UTC
Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | 325 CAPITAL LLC | $8,595,960 | 2026-06-30 | SEC 13F filing | 2026-11-20 11:17 UTC | Report an error |
| 2 | Bandera Partners LLC | $3,903,761 | 2026-06-30 | SEC 13F filing | 2026-11-20 11:17 UTC | Report an error |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | $2,084,203 | 2026-06-30 | SEC 13F filing | 2026-11-20 11:17 UTC | Report an error |
| 4 | MILLENNIUM MANAGEMENT LLC | $824,206 | 2026-06-30 | SEC 13F filing | 2026-11-20 11:17 UTC | Report an error |
| 5 | DIMENSIONAL FUND ADVISORS LP | $816,058 | 2026-06-30 | SEC 13F filing | 2026-11-20 11:17 UTC | Report an error |
| 6 | BlackRock, Inc. | $691,636 | 2026-06-30 | SEC 13F filing | 2026-11-20 11:17 UTC | Report an error |
| 7 | CITADEL ADVISORS LLC | $569,476 | 2026-06-30 | SEC 13F filing | 2026-11-20 11:17 UTC | Report an error |
| 8 | RICE HALL JAMES & ASSOCIATES, LLC | $496,771 | 2026-06-30 | SEC 13F filing | 2026-11-20 11:17 UTC | Report an error |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | $492,587 | 2026-06-30 | SEC 13F filing | 2026-11-20 11:17 UTC | Report an error |
| 10 | JANE STREET GROUP, LLC | $478,761 | 2026-06-30 | SEC 13F filing | 2026-11-20 11:17 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1819253.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001819253. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.